
| Biological Activity | |||||||||||||||||||||||||
| Synonyms | AT 406, AT406 cpd, SM-406, SM 406, SM406cpd | ||||||||||||||||||||||||
| Chemical Name | (5S,8S,10aR,Z)-N-benzhydryl-5-((Z)-((S)-1-hydroxy-2-(methylamino)propylidene)amino)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carbimidic acid | ||||||||||||||||||||||||
| Application | AT-406 is a potent and orally bioavailable antagonist of multiple inhibitor of apoptosis proteins (IAPs) | ||||||||||||||||||||||||
| CAS Number | 1071992-99-8 | ||||||||||||||||||||||||
| Purity | ≥99.0% | ||||||||||||||||||||||||
| Molecular Weight | 561.71 | ||||||||||||||||||||||||
| Molecular Formula | C₃₂H₄₃N₅O₄ | ||||||||||||||||||||||||
| SMILES | O=C([C@@H]1CC[C@@](CCN(C(CC(C)C)=O)C[C@@H]2NC([C@@H](NC)C)=O)([H])N1C2=O)NC(C3=CC=CC=C3)C4=CC=CC=C4 | ||||||||||||||||||||||||
| Target & IC50 | XIAP: IC50 = 66.4 nM cIAP1: IC50 = 1.9 nM cIAP2: IC50 = 5.1 nM |
||||||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||||||
| Storage | Store at -20°C | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Solubility | |
| DMSO: 93 mg/mL (165.6 mM) Ethanol: 93 mg/mL (165.6 mM) |
| Product Description | |
AT406 (SM-406, ARRY-334543) is a potent Smac mimetic and an antagonist of IAP (inhibitor of apoptosis protein via E3 ubiquitin ligase), binding to XIAP-BIR3, cIAP1-BIR3 and cIAP2-BIR3 with Ki of 66.4 nM, 1.9 nM, and 5.1 nM, 50- to 100-fold higher affinities than the Smac AVPI peptide. Phase 1 |